Introduction
Caffeine is one of the most widely used ingredients in the nutraceutical sector due to its ability to support mental alertness, focus, and physical performance. It is commonly included in formulations dedicated to energy, sport nutrition, cognitive performance, and weight management.
Despite its popularity, caffeine presents formulation challenges that may affect its effectiveness and tolerability. Among these are its characteristic bitter taste and rapid release, which may lead to concentration peaks followed by a rapid decline in perceived effect.
In this context, proprietary and patented MATRIS® technology enables the optimization of caffeine in nutraceutical applications through a functional microencapsulation approach designed for taste masking and prolonged release.
Formulation challenges
- strong bitter taste
• rapid release with short-lived effects
• difficulty in modulating duration of action
• potential gastrointestinal sensitivity in some formulations
IPS innovation: Caffeine MATRIS®
Caffeine MATRIS® is produced through direct microencapsulation of the active ingredient using proprietary patented MATRIS® technology.
Key technological benefits include:
- effective taste masking
- prolonged release through release modulation
- improved formulation stability
- better gastrointestinal tolerability
The coating system is designed to modulate release without altering the nature of the active ingredient.
Scientific evidence
The nutraceutical relevance of MATRIS® technology is supported by preclinical studies conducted on advanced in vitro 3D models and human intestinal and gastric organoids.
Observed benefits include:
- improved epithelial interaction
- reduced gastric impact
- improved tolerability
- more gradual and controlled release
- increased bioaccessibility
These outcomes are attributable to MATRIS® technology itself, which determines the gastrointestinal behavior of the microencapsulated ingredient.
Conclusion
With Caffeine MATRIS®, IPS transforms a widely used ingredient into a stable, tolerable, prolonged-release nutraceutical solution, reinforcing the role of SURACTIVES® by IPS as a technology provider in advanced nutraceutical design.
Note: This article is provided for informational purposes only and does not substitute professional medical advice.
